FLCA:NYE-Franklin FTSE Canada ETF (USD)

ETF | Miscellaneous Region |

Last Closing

USD 33.29

Change

-0.20 (-0.58)%

Market Cap

USD 0.39B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-01 )

Largest Industry Peers for Miscellaneous Region

Symbol Name Price(Change) Market Cap
EWY iShares MSCI South Korea ETF

N/A

USD 5.46B
EWU iShares MSCI United Kingdom ET..

N/A

USD 2.82B
EWC iShares MSCI Canada ETF

N/A

USD 2.39B
EWW iShares MSCI Mexico ETF

N/A

USD 1.83B
EWA iShares MSCI Australia ETF

N/A

USD 1.65B
EWL iShares MSCI Switzerland ETF

N/A

USD 1.15B
EWP iShares MSCI Spain ETF

N/A

USD 0.99B
EWG iShares MSCI Germany ETF

N/A

USD 0.91B
FLGB Franklin FTSE United Kingdom E..

N/A

USD 0.69B
EWQ iShares MSCI France ETF

N/A

USD 0.62B

ETFs Containing FLCA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Miscellaneous Region) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.15% 33% F 45% F
Dividend Return 1.10% 18% F 31% F
Total Return 1.25% 29% F 39% F
Trailing 12 Months  
Capital Gain 4.72% 39% F 53% F
Dividend Return 1.15% 8% B- 15% F
Total Return 5.86% 32% F 45% F
Trailing 5 Years  
Capital Gain 30.47% 85% B 67% D+
Dividend Return 10.30% 53% F 40% F
Total Return 40.77% 83% B 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 8.93% 66% D+ 68% D+
Dividend Return 10.87% 66% D+ 67% D+
Total Return 1.94% 58% F 45% F
Risk Return Profile  
Volatility (Standard Deviation) 19.36% 71% C- 53% F
Risk Adjusted Return 56.15% 83% B 78% C+
Market Capitalization 0.39B 68% D+ 42% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike